2.4. KRAS Inhibitors AMG510 and BI-3406 Inhibit KRAS Activation and Signaling through the RAS/MAPK Pathway in KRAS Mutant Pancreatic Cancer Cells. The gene discussed is KRAS; the disease is pancreatic neoplasm.